0001674335-19-000014.txt : 20190227
0001674335-19-000014.hdr.sgml : 20190227
20190227182316
ACCESSION NUMBER: 0001674335-19-000014
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190225
FILED AS OF DATE: 20190227
DATE AS OF CHANGE: 20190227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farmakis Peter
CENTRAL INDEX KEY: 0001695321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38000
FILM NUMBER: 19639501
MAIL ADDRESS:
STREET 1: JELD-WEN HOLDING, INC.
STREET 2: 440 S. CHURCH STREET, SUITE 400
CITY: CHARLOTTE
STATE: NC
ZIP: 28202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JELD-WEN Holding, Inc.
CENTRAL INDEX KEY: 0001674335
STANDARD INDUSTRIAL CLASSIFICATION: MILLWOOD, VENEER, PLYWOOD & STRUCTURAL WOOD MEMBERS [2430]
IRS NUMBER: 931273278
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2645 SILVER CRESCENT DRIVE
CITY: CHARLOTTE
STATE: NC
ZIP: 28273
BUSINESS PHONE: 704-378-5700
MAIL ADDRESS:
STREET 1: 2645 SILVER CRESCENT DRIVE
CITY: CHARLOTTE
STATE: NC
ZIP: 28273
4
1
wf-form4_155130978216414.xml
FORM 4
X0306
4
2019-02-25
0
0001674335
JELD-WEN Holding, Inc.
JELD
0001695321
Farmakis Peter
JELD-WEN HOLDING, INC.
2645 SILVER CRESCENT DRIVE
CHARLOTTE
NC
28273
0
1
0
0
EVP & President, Australasia
Common Stock
2019-02-25
4
A
0
8945
0
A
19281
D
Common Stock
2019-02-25
4
A
0
59637
0
A
78918
D
Common Stock
20.96
2019-02-25
4
A
0
22509
20.96
A
2029-02-25
Common Stock
22509.0
22509
D
The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 25, 2022.
The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest ratably on February 25, 2022 and February 25, 2023.
Subject to the reporting person's continued employment with the issuer, the options will vest ratably on February 25, 2020, February 25, 2021 and February 25, 2022.
/s/ Laura W. Doerre, Attorney-in-Fact for Peter Farmakis
2019-02-27